In the mild Alzheimer’s stage, a person is able to function independently but suffers from common difficulties. These include ...

For some people with a high risk of Alzheimer's who received a drug called gantenerumab for eight years, their risk of ...

The number of cases will increase, but the rates seem to be declining with every birth cohort that reaches advanced ages, ...

The probiotic-rich drink kefir may be a potential complementary treatment for Alzheimer’s disease by helping improve ...

New research shows Alzheimer's blood tests are 90% accurate for white patients but only 73% for Black patients, raising ...

A recent study determined the lifetime risk of developing dementia is double that of previous estimates. But there’s good ...

Medication options are available to help manage the cognitive and behavioral symptoms of dementia and Alzheimer's disease.

Several groundbreaking studies have examined the connection between hearing loss and Alzheimer’s risk: A Johns Hopkins ...

An early Alzheimer's treatment that removes amyloid plaques from the brain many years before symptoms arise may help delay ...

An experimental drug appears to reduce the risk of Alzheimer's-related dementia in people destined to develop the disease in their 30s, 40s or 50s, according to the results of a new study. The ...

A long-term human trial has found that a discontinued drug halved the presentation of early-onset Alzheimer's disease in ...

The findings provide new evidence to support the so-called amyloid hypothesis of Alzheimer's disease, which posits that the ...